TMT SPAC 890 5th Avenue Partners Files for $250M IPO

New SPAC 890 5th Avenue Partners filed to offer 25 million units at $10 each to raise $250 million in an IPO.

The SPAC is focused on the technology, media and telecomm space, especially companies with enterprise valuations in the range of $750 million to $2 billion or more. 

890 5th Avenue is led by Executive Chairman Adam Rothstein, co-founder and general partner of Disruptive Technology Partners, an Israeli technology-focused early-stage investment fund.

The SPAC intends to list on the Nasdaq under ENFAU. Read more.

Total
0
Shares
Related Posts
IPO
Read More

CA Healthcare Closes $115M IPO

The SPAC will target companies in the healthcare services, healthcare information technology, care management, behavioral health, medical devices, diagnostics, pharma services, health and wellness, and specialty pharmacy sectors.